Anthony T.�C. Chan

43.3k total citations · 8 hit papers
456 papers, 27.6k citations indexed

About

Anthony T.�C. Chan is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anthony T.�C. Chan has authored 456 papers receiving a total of 27.6k indexed citations (citations by other indexed papers that have themselves been cited), including 212 papers in Oncology, 146 papers in Otorhinolaryngology and 122 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anthony T.�C. Chan's work include Head and Neck Cancer Studies (146 papers), Viral-associated cancers and disorders (84 papers) and Lung Cancer Treatments and Mutations (61 papers). Anthony T.�C. Chan is often cited by papers focused on Head and Neck Cancer Studies (146 papers), Viral-associated cancers and disorders (84 papers) and Lung Cancer Treatments and Mutations (61 papers). Anthony T.�C. Chan collaborates with scholars based in Hong Kong, China and United States. Anthony T.�C. Chan's co-authors include Brigette Ma, Edwin P. Hui, Philip J. Johnson, Benny Zee, Frankie Mo, Quynh‐Thu Le, Qian Tao, Winnie Yeo, Jun Ma and Pierre Blanchard and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Anthony T.�C. Chan

447 papers receiving 27.1k citations

Hit Papers

Nasopharyngeal carcinoma 1999 2026 2008 2017 2019 2015 1999 2015 2007 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nasopharyngeal carcinoma
    2019 2.0k citations Yu‐Pei Chen, Anthony T.�C. Chan et al. The Lancet profile →
  2. Nasopharyngeal carcinoma
    2015 955 citations Edwin P. Hui, Anthony T.�C. Chan et al. The Lancet profile →
  3. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
    1999 626 citations Anthony T.�C. Chan et al. profile →
  4. Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
    2015 584 citations Brigette Ma, Anthony T.�C. Chan et al. Journal of Clinical Oncology profile →
  5. Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients
    2007 544 citations Michael K. M. Kam, Sing-Fai Leung et al. Journal of Clinical Oncology profile →
  6. Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
    2017 501 citations Ann D. King, Benny Zee et al. profile →
  7. Nasopharyngeal carcinoma: an evolving paradigm
    2021 315 citations Kenneth C.W. Wong, Edwin P. Hui et al. profile →
  8. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†
    2020 240 citations Anthony T.�C. Chan, Edwin P. Hui et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony T.�C. Chan Hong Kong 86 11.7k 10.2k 7.8k 7.2k 6.1k 456 27.6k
Everett E. Vokes United States 95 19.2k 1.6× 9.8k 1.0× 9.6k 1.2× 7.6k 1.0× 3.2k 0.5× 774 36.3k
Jean‐Pierre Pignon France 77 14.8k 1.3× 7.4k 0.7× 4.0k 0.5× 8.9k 1.2× 2.8k 0.5× 305 31.0k
Quynh‐Thu Le United States 79 7.8k 0.7× 7.4k 0.7× 6.7k 0.9× 5.8k 0.8× 5.2k 0.9× 461 25.4k
Eric K. Rowinsky United States 81 18.5k 1.6× 3.0k 0.3× 12.1k 1.6× 3.8k 0.5× 3.6k 0.6× 396 32.1k
Jennifer R. Grandis United States 75 10.5k 0.9× 4.2k 0.4× 10.6k 1.4× 3.1k 0.4× 4.1k 0.7× 342 23.4k
Adel K. El‐Naggar United States 99 16.8k 1.4× 5.4k 0.5× 12.0k 1.5× 11.9k 1.6× 5.1k 0.8× 679 36.4k
Roger B. Cohen United States 56 9.2k 0.8× 3.9k 0.4× 5.4k 0.7× 3.4k 0.5× 1.9k 0.3× 328 17.5k
Corey J. Langer United States 73 17.1k 1.5× 2.3k 0.2× 5.7k 0.7× 3.1k 0.4× 3.1k 0.5× 563 28.2k
Ezra E.W. Cohen United States 67 8.5k 0.7× 4.7k 0.5× 4.7k 0.6× 3.2k 0.4× 2.0k 0.3× 421 16.9k
José Baselga United States 98 25.8k 2.2× 3.3k 0.3× 19.7k 2.5× 3.6k 0.5× 9.8k 1.6× 484 46.7k

Countries citing papers authored by Anthony T.�C. Chan

Since Specialization
Citations

This map shows the geographic impact of Anthony T.�C. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony T.�C. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony T.�C. Chan more than expected).

Fields of papers citing papers by Anthony T.�C. Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony T.�C. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony T.�C. Chan. The network helps show where Anthony T.�C. Chan may publish in the future.

Co-authorship network of co-authors of Anthony T.�C. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony T.�C. Chan. A scholar is included among the top collaborators of Anthony T.�C. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony T.�C. Chan. Anthony T.�C. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Yu‐Pei, Anthony T.�C. Chan, Quynh‐Thu Le, et al.. (2019). Nasopharyngeal carcinoma. The Lancet. 394(10192). 64–80. 1996 indexed citations breakdown →
3.
Hui, Edwin P., Brigette Ma, Herbert H. Loong, et al.. (2018). Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study. Clinical Cancer Research. 24(5). 1030–1037. 41 indexed citations
4.
Ai, Qi Yong H., Ann D. King, Darren M.C. Poon, et al.. (2018). Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx. Oral Oncology. 88. 124–130. 54 indexed citations
5.
He, Wan, Charles Ming Lok Chan, Sze Chuen Cesar Wong, et al.. (2016). Jagged 2 silencing inhibits motility and invasiveness of colorectal cancer cell lines. Oncology Letters. 12(6). 5193–5198. 8 indexed citations
6.
Chan, Stephen L., Anthony W.H. Chan, Frankie Mo, et al.. (2016). Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma. Liver International. 37(2). 280–289. 32 indexed citations
7.
Chan, Stephen L., Frankie Mo, Philip J. Johnson, et al.. (2015). Applicability of BALAD score in prognostication of hepatitis B‐related hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 30(10). 1529–1535. 11 indexed citations
8.
Zheng, Yong, Greg Parsonage, Xiaodong Zhuang, et al.. (2015). Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma. Cancer Immunology Research. 3(10). 1138–1147. 28 indexed citations
9.
Taylor, Graham S., Hui Jia, Kevin J. Harrington, et al.. (2014). A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer. Clinical Cancer Research. 20(19). 5009–5022. 138 indexed citations
10.
Hui, Edwin P., Graham S. Taylor, Hui Jia, et al.. (2013). Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients. Cancer Research. 73(6). 1676–1688. 146 indexed citations
11.
Wong, Chi Hang, Herbert H. Loong, Connie W. C. Hui, et al.. (2013). Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma. Investigational New Drugs. 31(6). 1399–1408. 27 indexed citations
12.
13.
García‐Albéniz, Xabier, Hongmei Nan, Linda Valeri, et al.. (2012). Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival. Carcinogenesis. 34(2). 292–298. 17 indexed citations
14.
Cheng, Yingduan, Hua Geng, Suk Hang Cheng, et al.. (2010). KRAB Zinc Finger Protein ZNF382 Is a Proapoptotic Tumor Suppressor That Represses Multiple Oncogenes and Is Commonly Silenced in Multiple Carcinomas. Cancer Research. 70(16). 6516–6526. 113 indexed citations
15.
Lee, Aven, Ashley Anderson, Amanda C. Barnett, Anthony T.�C. Chan, & David V. Pow. (2010). Expression of multiple glutamate transporter splice variants in the rodent testis. Asian Journal of Andrology. 13(2). 254–265. 13 indexed citations
16.
Lui, Vivian Wai Yan, Elaine Yue Ling Wong, Yeung Ho, et al.. (2009). STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro. International Journal of Cancer. 125(8). 1884–1893. 61 indexed citations
17.
Wong, Sze Chuen Cesar, Charles Ming Lok Chan, Brigette Ma, et al.. (2009). Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients. Clinical Cancer Research. 15(3). 1005–1012. 64 indexed citations
18.
Hui, Edwin P., Brigette Ma, Sing Fai Leung, et al.. (2008). Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma. Journal of Clinical Oncology. 27(2). 242–249. 406 indexed citations
19.
Kam, Michael K. M., Sing-Fai Leung, Benny Zee, et al.. (2007). Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients. Journal of Clinical Oncology. 25(31). 4873–4879. 544 indexed citations breakdown →
20.
Bao, Yi, Chun Kwok Wong, Sing Fai Leung, et al.. (2006). Clinical Studies of Immunomodulatory Activities of Yunzhi-Danshen in Patients with Nasopharyngeal Carcinoma. The Journal of Alternative and Complementary Medicine. 12(8). 771–776. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Everett E. Vokes Breakdown of academic impact, for papers by Jean‐Pierre Pignon Breakdown of academic impact, for papers by Quynh‐Thu Le Breakdown of academic impact, for papers by Eric K. Rowinsky Breakdown of academic impact, for papers by Jennifer R. Grandis Breakdown of academic impact, for papers by Adel K. El‐Naggar Breakdown of academic impact, for papers by Roger B. Cohen Breakdown of academic impact, for papers by Corey J. Langer Breakdown of academic impact, for papers by Ezra E.W. Cohen Breakdown of academic impact, for papers by José Baselga
Rankless by CCL
2026